The latest news on healthcare and wellness

Provided by AGP

Global Healthcare Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Healthcare Today.

Press releases published on May 14, 2026

Tarsus and John Cena Partner to Raise Awareness of Demodex blepharitis, a Common Eyelid Disease Affecting Approximately 25 Million Americans
GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager for Solid Tumors
Microbot Medical Successfully Transitions to Commercial Operations as It Records Revenue Resulting from Its Limited Market Release During the First Quarter of 2026
CapeHaven Completes First Close of Funding and Initiates Operations to Encourage Yale’s Biotech Spinouts
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Responds to BBB Challenge with Next-Gen Drug-Delivery Platform
SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Developing Distinct Next-Gen GLP-1 Built Around Novel Peptide
MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Harnesses Key AI, Voice Analysis to Offer Impairment Solution
Vor Bio Announces Publication of Interim Analysis of TELIGAN, a China Phase 3 Trial of Telitacicept in IgA Nephropathy, in The New England Journal of Medicine
Candel Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
Prenetics Welcomes Brian J. Rosin as Chief Financial Officer of IM8
OrganOx Announces Appointment of Naoya Iwata as CEO & President
INmune Bio Receives FDA Fast Track Designation for XPro1595 in Early Alzheimer's Disease
Koelis Announces ProMap® Smart Automatic Prostate Contouring Software at AUA 2026
Kyverna Therapeutics to Present at Upcoming Investor Conferences
Keros Therapeutics Reports Recent First Quarter 2026 Financial Results
Menarini Group Announces New Data at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting
Forward Therapeutics Announces Completion of Phase 1 Trials with Two Internally Discovered Next-Generation TNF Signaling Inhibitors Supporting Advancement to Phase 2 Clinical Development
AUA Guidelines Strengthen Recommendation for Aquablation® Therapy
Cingulate Inc. Reports First Quarter 2026 Financial Results and Provides an Update of Commercial Readiness Efforts On Track for lead ADHD Asset CTx-1301
Apyx Medical Corporation Announces Retrospective Clinical Publication Evaluating Clinical Benefit of Renuvion® Used in Combination with Liposuction

Share us

on your social networks:

Sign up for:

Global Healthcare Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.